pharmakinetics Flashcards

1
Q

Dose-concentration relationship
Effects of the biologic system on
drugs

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Deals with the processes of absorption,
distribution and elimination of drugs
Makes possible the calculation of loading
and maintenance doses

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Concentration of a drug at the receptor site
(in contrast to drug concentrations that are
more rapidly measured, eg, blood)

A

EFFECTIVE DRUG CONCENTRATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rate of input of the drug (by absorption)
into the plasma
Rate of distribution to peripheral tissues
(including the target organ)
Rate of elimination, or loss, from the body

A

PLASMA CONCENTRATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 BASIC PARAMETERS

A

 Unique for a particular drug in a particular
patient
 Average values in large populations that
can be used to predict concentrations
1. VOLUME OF DISTRIBUTION (Vd)
2. CLEARANCE (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 BASIC PARAMETERS

Measure of apparent space in the body
available to contain the drug
Amount of drug in the body to the
plasma/serum concentration
Intracellular and extracellular
compartments
A

VOLUME OF DISTRIBUTION (Vd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

OLUME OF DISTRIBUTION (Vd) EQUATION

A

Amount of drug in the body
OVER
Plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
When a drug is avidly bound in
peripheral tissues, it’s concentration
in plasma may drop to very low values
even if the total amount in the body is
large
A

High volume of distribution (Vd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When a drug is completely retained in

the plasma compartment

A

 Volume of distribution is equal to the

plasma volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 BASIC PARAMETERS

Rate of elimination compared to plasma
concentration
Depends on the drug and the organs of
elimination in the patient

A

CLEARANCE (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs eliminated with first-order kinetics
Clearance is a constant
Elimination rate is equal to clearance times
plasma concentration
Elimination will be rapid at first and slow as the
concentration decreases

A

CLEARANCE (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clearance equation

A

CLEARANCE (CL)
Rate of elimination of drug
over
Plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q


Time it takes for the amount or concentration
of a drug to fall to 50% of an earlier
measurement

A

HALF LIFE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Constant regardless of concentration

A

Drugs eliminated by first-order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Particularly useful

Not a constant

A

Drugs eliminated by zero-order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Derived parameter from the volume of
distribution and clearance
Determines the rate at which blood
concentration rises during a constant
infusion and falls after administration is
stopped
A

HALF LIFE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HALF LIFE EQUATION

A

HALF LIFE
0.693 x Vd
OVER
CL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Rate of drug administration is equal to
rate of elimination
Dose in=dose out

A

STEADY STATE CONCENTRATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fraction of the administered dose of the
drug that reaches the systemic circulation
Equal to the amount absorbed over the
amount administered

A

BIOAVAILABILITY

20
Q

BIOAVAILABILITY

Dependent on

A
Extent of absorption
1 st-pass effect
Rate of absorption
Site of administration
[eg, topical drugs (ointments) which
have very slow rate of absorption]
21
Q

BIOAVAILABILITY

Drugs are more absorbed in the because it has a

A

small
intestines
larger surface
area

22
Q

BIOAVAILABILITY
TYPE OF ADMIN THAT GIVES
Unity or 100%

A

Intravenous administration

23
Q
BIOAVAILABILITY
TYPE OF ADMIN
Reduced by incomplete absorption
1 st-pass metabolism
Distribution into other tissues before the
drug enters the systemic circulation
A

Administration by other routes

24
Q

WHAT TO DO TO To offset low bioavailability

A
Sublingual
Rectal-50% probability of bypassing
the 1 st-pass effect
Inhalation or nasal
Transdermal patches
25
Q

TIME COURSE OF DRUG EFFECTS

Directly related to concentration
Eg, anticoagulants

A
  1. IMMEDIATE EFFECT
26
Q

TIME COURSE OF DRUG EFFECTS

Due to distributional delay
Delayed expression of the physiologic
substance needed for the effect

A
  1. DELAYED EFFECT
27
Q

TIME COURSE OF DRUG EFFECTS

Constant infusion
Aminoglycosides causes renal toxicity
if given constantly
Intermittent dosing only

A
  1. CUMULATIVE EFFECTS
28
Q
Fraction of the drug removed from the
perfusing blood during passage to the
organ
Measure of the elimination of the drug by
that organ
Drugs with high hepatic extraction ratio
have large 1 st-pass effect
A

EXTRACTION

29
Q

Desired therapeutic effects are produced

A

TARGET CONCENTRATION

30
Q
Plan for drug administration over a period
of time
Achievement of therapeutic levels of the
drug in the body without exceeding the
minimum toxic concentration
A

DOSAGE REGIMENS

31
Q
Dose needed to maintain a steady state of
concentration
Maintain plasma concentration within a
specified range over long periods of
therapy
Enough drugs to replace eliminated drugs
Clearance is the most important parameter
in defining rational drug dosage
A

MAINTENANCE DOSE

32
Q

For drugs with long half-lives and longer
time to reach a steady state
Given to promptly raise the concentration
of the drug to the target concentration

A

LOADING DOSE

33
Q
LOADING DOSE
If the therapeutic concentration must be
achieved rapidly and the volume of
distribution is large, a --- loading dose
maybe needed at the onset of therapy
Volume of distribution (Vd) is important
A

large

34
Q

PHARMACOKINETIC VARIABLES

Compliance of patient is important
Variation in bioavailability are usually
due to variation in metabolism during
absorption

A
  1. ABSORPTION
35
Q

A. PHARMACOKINETIC VARIABLES

Most important parameter in designing
dosage regimen
Creatinine clearance

A
  1. CLEARANCE
36
Q
  • Good indicator of renal function
  • Adjust the dosage of the drug
  • No reliable indicator for liver function
A

CREATININE CLEARANCE

37
Q

PHARMACOKINETIC VARIABLES

Clearance and volume of distribution

A
  1. HALF LIFE
38
Q

PHARMACODYNAMIC VARIABLES

Emax
No more increase in effect even if the
concentration is increasing

A
  1. MAXIMUM EFFECT
39
Q

A. PHARMACODYNAMIC VARIABLES

Increased, exaggerated response to
small doses

A
  1. SENSITIVITY
40
Q

More highly protein bound drug will
displace the less protein bound drug
Inert

A

PLASMA BINDING PROTEINS

41
Q

Most appropriate time to measure drug

concentration

A

Absorption is complete

2 hours after the dose

42
Q

PLASMA BINDING PROTEINS
Acidic drugs bind to —-
Basic drugs bind to —–

A

albumin

alpha 1 acid glycoprotein

43
Q

PLASMA BINDING PROTEINS
More highly protein bound drug will
displace the —— drug
Inert

A

less protein bound

44
Q
Average total amount of drug in the body
does not change over multiple dosing
intervals
Rate of drug input equals the rate of
elimination
Condition in 3 to 4 t ½ must elapse before
checking drug blood concentration
A

STEADY STATE CONCENTRATION

45
Q
Safe “opening” between the MEC and
the MTC of the drug
Used to determine the range of plasma
levels that is acceptable when designing
a dosing regimen
A

THERAPEUTIC WINDOW

46
Q
PEAK AND TROUGH
CONCENTRATIONS
determines the desired trough
levels of a drug given intermittently
MTC determines the permissible peak
plasma concentration
A

MEC

47
Q

PEAK AND TROUGH
CONCENTRATIONS
determines the permissible peak
plasma concentration

A

MTC